Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 811-820 Newer>

BusinessWeek July 28, 2003 John Carey	The Hundred Years' War at the FDA Philip J. Hilts's often fascinating new history of the Food & Drug Administration, Protecting America's Health: The FDA, Business, and One Hundred Years of Regulation teaches that in order to look after the public and advance medicine, there's no substitute for scientific testing.
Bio-IT World July 15, 2003 Salvatore Salamone	Buying Power Celera's decision to replace its Compaq supercomputer with IBM and EMC is surprising. It also provides a fascinating how to procurement model for the bio-IT industry.
Bio-IT World July 15, 2003	Millennium's PARIS Illuminates Pathways To address high-throughput-data challenges, Millennium Pharmaceuticals built the PAthway Resource and Information System, or PARIS -- a unique platform for combining knowledge from heterogeneous data sources in the construction of a pathway knowledgebase.
Bio-IT World July 15, 2003	The BRAIN Behind BCM's Clinical Trials What ultimately came to be called the Biomedical Research and Information Network, or BRAIN, took two years to build and cost Baylor College of Medicine $1.5 million. Yet no one doubts the value of the investment.
Bio-IT World July 15, 2003	Solutia Streamlines Route from Lab to Production Solutia Pharmaceutical Services, under pressure to control costs, built a single, integrated software application that enables management and control of every resource used in the development and manufacture of API (active pharmaceutical ingredient) products.
Bio-IT World July 15, 2003 Mark D. Uehling	Patient, Record Thyself As e-diaries get a boost -- and a knock -- from the FDA, Invivodata focuses on helping patients log their experiences.
Bio-IT World July 15, 2003 Michael Greeley	Finally, the Bottom Has pharma bought all the solutions it needs? The flood of genomic data indicates no.
Wired August 2003 Jennifer Kahn	The End of Cancer (As we Know it) Diagnosis. Chemotherapy. Radiation. Slow painful death. No more. A new era of cancer treatment is dawning. Meet three scientists who are using the revelations of the Human Genome Project to reshape medicine.
BusinessWeek July 21, 2003 Amy Barrett	A Bare-Knuckle Battle over Cholesterol Drugs If AstraZeneca's Crestor is approved, rivals' stepped-up pitches will focus on safety
BusinessWeek July 14, 2003 Robert J. Barro	Medicare: Forget the Drug Benefit, and Face Up to Real Reforms Washington seems poised to make a major error on Medicare. The program's costs are out of control, and the situation will deteriorate further as the population ages. We should be considering basic changes to the structure of the health-care market.
<Older 811-820 Newer> Return to current articles.